This study is NOT currently recruiting participants.
Number
20-C-0130
Sponsoring Institute
National Cancer Institute (NCI)
Recruitment Detail
Type: Completed Study; data analyses ongoing Gender: Male & Female Min Age: 12 Years Max Age: 120 Years
Referral Letter Required
No
Population Exclusion(s)
Non-English Speaking
Keywords
Telehealth; Self-Reported Pain; Facial Recognition Technology; Pain Score; Natural History
Recruitment Keyword(s)
None
Condition(s)
Cancer; Neoplasms; Solid Tumors
Investigational Drug(s)
Investigational Device(s)
Intervention(s)
Supporting Site
National Cancer Institute
Cancer pain can have a very negative effect on people s daily lives. Researchers want to use machine learning to detect facial expressions and voice signals. They want to help people with cancer by creating a model to measure pain. They want the model to reflect diverse faces and facial expressions.
Objective:
To find out whether facial recognition technology can be used to classify pain in a diverse set of people with cancer. Also, to find out whether voice recognition technology can be used to assess pain.
Eligibility:
People ages 12 and older who are undergoing treatment for cancer
Design:
Participants will be screened with:
Cancer history
Information about their gender and skin type
Information about their access to a smart phone and wireless internet
Questions about their cancer pain
Participants will have check-ins at the clinic and at home. These will occur over about 3 months. They will have 2-4 check-ins at the clinic. They will check in at home about 3 times per week.
During check-ins, participants will answer questions and talk about their cancer pain. They will use a mobile phone or a computer with a camera and microphone to complete a questionnaire. They will record a video of themselves reading a 15-second passage of text and responding to a question.
During the clinic check-ins, professional lighting, video equipment, and cameras will be used for the recordings.
During remote check-ins, participants will be asked to complete the questionnaire and recordings alone. They should be in a quiet and bright room. The room should have a white wall or background.
--Back to Top--
INCLUSION CRITERIA: 1. Ability of subject to understand and willingness to sign a written informed consent document. 2. Adults and children (including NIH staff) aged >= 12 years. 3. Participants with diagnosis of a cancer or tumor 4. Participant must be receiving either standard of care or investigational cancer/tumor treatment either at NIH or with a community physician. 5. Must have access to a smart phone (iPhone or Android) with either a data plan and/or access to wireless internet (wifi) or a computer with a camera and microphone and access to internet and must willing to use their device and assume any associated charges from service providers. EXCLUSION CRITERIA: 1. Participants with progressive brain tumors or metastasis. Participants with treated brain metastasis or primary brain tumor are eligible if there is no evidence of progression for at least 4 weeks after CNS directed treatment and there is no impact on voice or facial muscle movements. 2. Participants with Parkinson s disease. 3. Known current alcohol or drug abuse. 4. Any psychiatric condition that would prohibit the understanding or rendering of informed consent. 5. Non-English speaking subjects.
1. Ability of subject to understand and willingness to sign a written informed consent document.
2. Adults and children (including NIH staff) aged >= 12 years.
3. Participants with diagnosis of a cancer or tumor
4. Participant must be receiving either standard of care or investigational cancer/tumor treatment either at NIH or with a community physician.
5. Must have access to a smart phone (iPhone or Android) with either a data plan and/or access to wireless internet (wifi) or a computer with a camera and microphone and access to internet and must willing to use their device and assume any associated charges from
service providers.
EXCLUSION CRITERIA:
1. Participants with progressive brain tumors or metastasis. Participants with treated brain metastasis or primary brain tumor are eligible if there is no evidence of progression for at least 4 weeks after CNS directed treatment and there is no impact on voice or facial muscle movements.
2. Participants with Parkinson s disease.
3. Known current alcohol or drug abuse.
4. Any psychiatric condition that would prohibit the understanding or rendering of informed consent.
5. Non-English speaking subjects.
Principal Investigator
Referral Contact
For more information: